Operating Income for Labcorp Holdings (LH)
According to Labcorp Holdings's latest reported financial statements, the company's current operating income (TTM) is $1.50B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$1.50B
YoY change
+39.5%
5Y CAGR
-9.1%
Peak year (2021)
$3.05B
Cumulative operating income
$28.89B
Operating Income history chart for Labcorp Holdings (LH) from 1988 to 2025
Operating Income history table for Labcorp Holdings (LH) from 1988 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $1.52B | +39.5% | ||
| 2024 | $1.09B | +49.8% | ||
| 2023 | $725.60M | -49.5% | ||
| 2022 | $1.44B | -52.9% | ||
| 2021 | $3.05B | +24.7% | ||
| 2020 | $2.45B | +83.8% | ||
| 2019 | $1.33B | +0.3% | ||
| 2018 | $1.33B | -2.8% | ||
| 2017 | $1.36B | +3.9% | ||
| 2016 | $1.31B | +30.9% | ||
| 2015 | $1.00B | +10.2% | ||
| 2014 | $910.40M | -8.1% | ||
| 2013 | $990.90M | -3.2% | ||
| 2012 | $1.02B | +7.9% | ||
| 2011 | $948.40M | -3.1% | ||
| 2010 | $978.80M | +4.6% | ||
| 2009 | $935.90M | +11.0% | ||
| 2008 | $842.90M | +8.5% | ||
| 2007 | $777.00M | +11.5% | ||
| 2006 | $697.10M | +12.8% | ||
| 2005 | $618.10M | +3.3% | ||
| 2004 | $598.40M | +12.1% | ||
| 2003 | $533.70M | +22.7% | ||
| 2002 | $435.00M | +18.3% | ||
| 2001 | $367.60M | +47.0% | ||
| 2000 | $250.10M | +67.1% | ||
| 1999 | $149.70M | +17.3% | ||
| 1998 | $127.60M | -238.7% | ||
| 1997 | -$92.00M | -4.0% | ||
| 1996 | -$95.80M | -242.6% | ||
| 1995 | $67.20M | -38.9% | ||
| 1994 | $109.90M | -40.8% | ||
| 1993 | $185.50M | -7.3% | ||
| 1992 | $200.10M | +15.3% | ||
| 1991 | $173.50M | +23.6% | ||
| 1990 | $140.40M | +24.5% | ||
| 1989 | $112.80M | -64.1% | ||
| 1988 | $313.90M | — |
Operating Income values are taken from Labcorp Holdings's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Labcorp Holdings (LH) most recent annual operating income stands at $1.52B (2025) – surged 39.5% year-over-year.
Labcorp Holdings operating income compound annual growth for the 2020–2025 (5 years) window is -9.1%, sustaining 2 straight years of year-over-year growth.
Between 2021 and 2025, Labcorp Holdings operating income plunged 50.3%, falling from $3.05B to $1.52B.
Across the available history, operating income reached its high of $3.05B in 2021 and its low of -$95.80M in 1996.
Within Healthcare, Labcorp Holdings (LH) ranks 9th among 8 peers we track. The peer median for operating income is $22.84B.
Labcorp Holdings Operating Income by Year
Labcorp Holdings Operating Income 2025: $1.52B
Labcorp Holdings operating income in 2025 was $1.52B, surged 39.5% from 2024.
Labcorp Holdings Operating Income 2024: $1.09B
Labcorp Holdings operating income in 2024 was $1.09B, surged 49.8% from 2023.
Labcorp Holdings Operating Income 2023: $725.60M
Labcorp Holdings operating income in 2023 was $725.60M, plunged 49.5% below 2022.
Labcorp Holdings Operating Income 2022: $1.44B
Labcorp Holdings operating income in 2022 was $1.44B, plunged 52.9% below 2021.
Labcorp Holdings Operating Income 2021: $3.05B
Labcorp Holdings operating income in 2021 was $3.05B.
See more financial history for Labcorp Holdings (LH).
Sector peers — Operating Income
Companies in the same sector as Labcorp Holdings, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Labcorp Holdings's operating income?
- Latest reported operating income for Labcorp Holdings (LH) is $1.50B (period ending December 31, 2025).
How has Labcorp Holdings operating income changed year-over-year?
- Labcorp Holdings (LH) operating income changed +39.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Labcorp Holdings operating income?
- Labcorp Holdings (LH) operating income compound annual growth rate is -9.1% over the most recent 5 years available.
When did Labcorp Holdings operating income hit its highest annual value?
- Labcorp Holdings operating income reached its highest annual value of $3.05B in 2021.
What was Labcorp Holdings operating income in 2024?
- Labcorp Holdings (LH) operating income in 2024 was $1.09B.
What was Labcorp Holdings operating income in 2025?
- Labcorp Holdings (LH) operating income in 2025 was $1.52B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LH Overview
Company profile, financial tools, and key metrics
LH Revenue Counter
Earns $442.41 every second. See per minute, hour, and day.
LH Earnings Counter
Earns $27.79 per second net profit. See per minute, hour, and day.
LH Economic Scale
Exceeds West Bank and Gaza's GDP. Compare with world economies.
LH What If Invested
What if you had invested $1,000? See historical returns from any date.
LH How It Makes Money
Discover visual breakdown of $13.95B in revenue — where it comes from and where it goes.
LH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LH Daily Price Character
Balanced · 47.4% historical win rate (green days). Streaks & record days.
LH Buybacks
2.17% TTM buyback yield. Shareholder yield & SBC comparison.
LH Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LH Dividend Profile
Yield: 1.12%. Safety: 4/6. See full history.
LH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.